Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: A case-control study

Vaccine

Volumn 27, Issue 33, 2009, Pages 4457-4461

  Joshi, Avni Y ^a,b   Iyer, Vivek N ^a   St Sauver, Jennifer L ^b   Jacobson, Robert M ^b   Boyce, Thomas G ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Children; Effectiveness; Influenza; Trivalent Inactivated Influenza vaccine (TIV)

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MINNESOTA; SEASONS; TREATMENT OUTCOME; VACCINATION; VACCINES, INACTIVATED;

EID: 67649378412     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.038     Document Type: Article

References (17)

1. Glezen W.P. Influenza vaccination for healthy children. Curr Opin Infect Dis 15 3 (2002) 283-287
2. Jacobson R.M., and Poland G.A. Universal vaccination of healthy children against influenza: a role for the cold-adapted intranasal influenza vaccine. Paediatr Drugs 4 1 (2002) 65-71
3. Greenberg H.B., and Piedra P.A. Immunization against viral respiratory disease: a review. Pediatr Infect Dis J 23 Suppl. 11 (2004) S254-S261
4. Monto A.S. Epidemiology of viral respiratory infections. Am J Med 112 Suppl. 6A (2002) 4S-12S
5. Neuzil K.M., Jackson L.A., Nelson J., Klimov A., Cox N., Bridges C.B., et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 194 8 (2006) 1032-1039
6. Fiore A.E., Shay D.K., Haber P., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56 RR-6 (2007) 1-54
7. Dwyer D.E., Smith D.W., Catton M.G., and Barr I.G. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 185 Suppl. 10 (2006) S48-S53
8. Sinclair J.C., Cook R.J., Guyatt G.H., Pauker S.G., and Cook D.J. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol 54 3 (2001) 253-262
9. Aymard M., Valette M., and Luciani J. Burden of influenza in children: preliminary data from a pilot survey network on community diseases. Pediatr Infect Dis J 22 Suppl. 10 (2003) S211-S214
10. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine-Marshfield, Wisconsin, 2007-2008 influenza season. MMWR Morb Mortal Wkly Rep 57 15 (2008) 393-398
11. Edwards K.M., and Griffin M.R. Influenza vaccination of children: can it be accomplished?. J Infect Dis 194 8 (2006) 1027-1029
12. Cohen G.M., and Nettleman M.D. Economic impact of influenza vaccination in preschool children. Pediatrics 106 5 (2000) 973-976
13. Meltzer M.I., Neuzil K.M., Griffin M.R., and Fukuda K. An economic analysis of annual influenza vaccination of children. Vaccine 23 8 (2005) 1004-1014
14. White T., Lavoie S., and Nettleman M.D. Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics 103 6 (1999) e73
15. Sackett D.L. Bias in analytic research. J Chronic Dis 32 1-2 (1979) 51-63
16. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 199 2 (2009) 159-167
17. Melton III L.J. History of the Rochester Epidemiology Project. Mayo Clin Proc 71 3 (1996) 266-274